本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Akero Therapeutics

54.65
0.0000
成交量:- -
成交額:8.36億
市值:44.99億
市盈率:-14.61
高:54.65
開:54.65
低:54.65
收:54.65
52周最高:58.40
52周最低:21.34
股本:8,232.44萬
流通股本:6,777.24萬
量比:- -
換手率:- -
股息:- -
股息率:- -
每股收益(TTM):-3.7418
每股收益(LYR):-3.7544
淨資產收益率:-34.53%
總資產收益率:-22.63%
市淨率:4.70
市盈率(LYR):-14.56

資料載入中...

2024/02/14

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/13

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/08

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/07

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/12/30

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/12/18

重要事件披露

Form 8-K - Current report
2023/11/13

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/13

重要事件披露

Form 8-K - Current report
2023/10/10

重要事件披露

Form 8-K - Current report
2023/10/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/10/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/09/12

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/08/28

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/08/11

重要事件披露

Form 8-K - Current report
2023/08/11

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/07/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/06/26

重要事件披露

Form 8-K - Current report
2023/06/26

關聯方擬減持公告

Form 144 - Report of proposed sale of securities